212 related articles for article (PubMed ID: 35156069)
1. Prevalence of nasopharyngeal
Hart JD; Samikwa L; Meleke H; Burr SE; Cornick J; Kalua K; Bailey RL
Lancet Microbe; 2022 Feb; 3(2):e142-e150. PubMed ID: 35156069
[TBL] [Abstract][Full Text] [Related]
2. Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control.
Bojang E; Jafali J; Perreten V; Hart J; Harding-Esch EM; Sillah A; Mabey DC; Holland MJ; Bailey RL; Roca A; Burr SE
BMC Microbiol; 2017 Mar; 17(1):75. PubMed ID: 28351345
[TBL] [Abstract][Full Text] [Related]
3. Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger.
Hazel A; Arzika AM; Abdou A; Lebas E; Porco TC; Maliki R; Doan T; Lietman TM; Keenan JD; Blumberg S
Am J Trop Med Hyg; 2023 Nov; 109(5):1107-1112. PubMed ID: 37783458
[TBL] [Abstract][Full Text] [Related]
4. Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).
Arzika AM; Abdou A; Maliki R; Beido N; Kadri B; Harouna AN; Galo AN; Alio MK; Lebas E; Oldenburg CE; O'Brien KS; Chen C; Zhong L; Zhou Z; Yan D; Hinterwirth A; Keenan JD; Porco TC; Lietman TM; Doan T;
PLoS Med; 2024 May; 21(5):e1004386. PubMed ID: 38709718
[TBL] [Abstract][Full Text] [Related]
5. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.
Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S
Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375
[TBL] [Abstract][Full Text] [Related]
6. Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania.
Bloch EM; Coles CL; Kasubi M; Weaver J; Mrango Z; Munoz B; Lietman TM; West SK
Am J Trop Med Hyg; 2020 Sep; 103(3):1301-1307. PubMed ID: 32067633
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Antibiotic Selection Pressure on the Nasopharyngeal Macrolide Resistome: A Cluster-randomized Trial.
Keenan JD; Chin SA; Amza A; Kadri B; Nassirou B; Cevallos V; Cotter SY; Zhou Z; West SK; Bailey RL; Porco TC; Lietman TM;
Clin Infect Dis; 2018 Nov; 67(11):1736-1742. PubMed ID: 29897440
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial.
Skalet AH; Cevallos V; Ayele B; Gebre T; Zhou Z; Jorgensen JH; Zerihun M; Habte D; Assefa Y; Emerson PM; Gaynor BD; Porco TC; Lietman TM; Keenan JD
PLoS Med; 2010 Dec; 7(12):e1000377. PubMed ID: 21179434
[TBL] [Abstract][Full Text] [Related]
9. Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.
Hare KM; Grimwood K; Chang AB; Chatfield MD; Valery PC; Leach AJ; Smith-Vaughan HC; Morris PS; Byrnes CA; Torzillo PJ; Cheng AC
Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2275-85. PubMed ID: 26363637
[TBL] [Abstract][Full Text] [Related]
10. Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.
Doan T; Worden L; Hinterwirth A; Arzika AM; Maliki R; Abdou A; Zhong L; Chen C; Cook C; Lebas E; O'Brien KS; Oldenburg CE; Chow ED; Porco TC; Lipsitch M; Keenan JD; Lietman TM
N Engl J Med; 2020 Nov; 383(20):1941-1950. PubMed ID: 33176084
[TBL] [Abstract][Full Text] [Related]
11. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial.
Keenan JD; Arzika AM; Maliki R; Elh Adamou S; Ibrahim F; Kiemago M; Galo NF; Lebas E; Cook C; Vanderschelden B; Bailey RL; West SK; Porco TC; Lietman TM;
Lancet Glob Health; 2020 Feb; 8(2):e288-e295. PubMed ID: 31981558
[TBL] [Abstract][Full Text] [Related]
12. Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control.
Seidman JC; Coles CL; Silbergeld EK; Levens J; Mkocha H; Johnson LB; Muñoz B; West SK
Int J Epidemiol; 2014 Aug; 43(4):1105-13. PubMed ID: 24659584
[TBL] [Abstract][Full Text] [Related]
13. Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.
Keenan JD; Bailey RL; West SK; Arzika AM; Hart J; Weaver J; Kalua K; Mrango Z; Ray KJ; Cook C; Lebas E; O'Brien KS; Emerson PM; Porco TC; Lietman TM;
N Engl J Med; 2018 Apr; 378(17):1583-1592. PubMed ID: 29694816
[TBL] [Abstract][Full Text] [Related]
14. Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).
O'Brien KS; Arzika AM; Amza A; Maliki R; Ousmane S; Kadri B; Nassirou B; Mankara AK; Harouna AN; Colby E; Lebas E; Liu Z; Le V; Nguyen W; Keenan JD; Oldenburg CE; Porco TC; Doan T; Arnold BF; Lietman TM;
BMC Public Health; 2021 Apr; 21(1):822. PubMed ID: 33926403
[TBL] [Abstract][Full Text] [Related]
15. Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx.
Gladstone RA; Bojang E; Hart J; Harding-Esch EM; Mabey D; Sillah A; Bailey RL; Burr SE; Roca A; Bentley SD; Holland MJ
Clin Microbiol Infect; 2021 Jun; 27(6):864-870. PubMed ID: 32750538
[TBL] [Abstract][Full Text] [Related]
16. Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial.
Arzika AM; Maliki R; Boubacar N; Kane S; Cotter SY; Lebas E; Cook C; Bailey RL; West SK; Rosenthal PJ; Porco TC; Lietman TM; Keenan JD;
PLoS Med; 2019 Jun; 16(6):e1002835. PubMed ID: 31237871
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial.
Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL
Am J Trop Med Hyg; 2020 Sep; 103(3):1283-1290. PubMed ID: 32342840
[TBL] [Abstract][Full Text] [Related]
18. Effect of Biannual Azithromycin to Children under 5 Years on the Carriage of Respiratory Pathogens among Children Aged 7-11 Years.
Brennhofer SA; Rogawski McQuade ET; Zhang J; Pholwat S; Stroup S; Platts-Mills JA; Liu J; Houpt ER
Am J Trop Med Hyg; 2023 Feb; 108(2):428-432. PubMed ID: 36535258
[TBL] [Abstract][Full Text] [Related]
19. Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae.
Batt SL; Charalambous BM; Solomon AW; Knirsch C; Massae PA; Safari S; Sam NE; Everett D; Mabey DC; Gillespie SH
Antimicrob Agents Chemother; 2003 Sep; 47(9):2765-9. PubMed ID: 12936971
[TBL] [Abstract][Full Text] [Related]
20. Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia.
Burr SE; Milne S; Jafali J; Bojang E; Rajasekhar M; Hart J; Harding-Esch EM; Holland MJ; Mabey DC; Sillah A; Bailey RL; Roca A
Bull World Health Organ; 2014 Jul; 92(7):490-8. PubMed ID: 25110374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
